Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Hki-357 | 848133-17-5 | MFCD26792555 | 98.1% | 574.05 g·mol⁻¹ | C31H29ClFN5O3 | 1 MG
SDP

Supplier:  Medchemexpress LLC HY1034431MG

Encompass_Preferred

HKI-357 is a small-molecule, irreversible dual inhibitor of EGFR and ERBB2 tyrosine kinases intended for research use. It shows low-nanomolar potency and suppresses EGFR autophosphorylation and downstream signaling, making it useful for cellular and biochemical studies of EGFR/HER2 pathways.

  • Irreversible dual inhibition of EGFR and ERBB2.
  • Reported potency: EGFR IC50 ≈ 34 nM; ERBB2 IC50 ≈ 33 nM.
  • Suppresses EGFR autophosphorylation at Y1068 and downstream AKT and MAPK phosphorylation.
  • Supplied as a solid research compound with recommended cold storage for long-term stability.
  • Molecular formula C31H29ClFN5O3; molecular weight 574.05 g·mol⁻¹.

Catalog No. 50-002-46336


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.